患者因心脏衰竭首次住院时的年龄的种族和种族差异
Xiaoning Huang1, Zachary Hughes1, Gregg C Fonarow2
1Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Journal of the American College of Cardiology
|September 3, 2025
概括
在心力衰竭 (HF) 住院年龄方面存在种族和种族差异. 与非西班牙裔白人患者相比,非西班牙裔亚裔,非西班牙裔黑人和西班牙裔患者的住院年龄显著增加了社会和临床因素.
科学领域:
- 心脏病学
- 公共卫生
- 健康上的差异
背景情况:
- 心力衰竭 (HF) 的负担不成比例地影响着各种种族和族群.
- 对于有针对性的干预措施来说,了解高频率的年龄差异至关重要.
- 现有研究强调了不同人群中HF患病率和结果的差异.
研究的目的:
- 分析不同种族和族群首次心力衰竭 (HF) 住院的年龄.
- 量化社会风险因素对HF住院年龄观察到的种族和种族差异的影响.
- 确定导致HF早期发病差异的具体因素.
主要方法:
- 使用了"与指导方针-心力衰竭 (GWTG-HF) "注册表 (2016-2019) 的数据.
- 包括因HF而入院的没有先前诊断的患者.
- 使用Oaxaca-Blinder分解来评估临床和社会因素对年龄差异的贡献.
主要成果:
- 非西班牙裔 (NH) 亚裔,NH黑人和西班牙裔患者在首次HF住院时比NH白人患者年轻得多.
- 第一次入院的平均年龄:NH亚裔 (70.6),NH黑人 (60.1),西班牙裔 (65.4),NH白人 (73.6岁).
- 社会和临床因素导致了显著的年龄差异:1.2年 (NH亚裔),12.5年 (NH黑人) 和7.4年 (西班牙裔).
结论:
- 非西班牙裔亚洲人,非西班牙裔黑人和西班牙裔个人比NH白人更年轻时首次住院.
- 这些年龄差异的很大一部分是由于社会和临床风险因素的差异.
- 解决健康的社会决定因素对于缓解HF差异至关重要.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.2K
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.7K
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
01:27Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
01:26Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
02:55Stereotypes, Prejudice, and Discrimination
91.4K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
91.4K
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27